Safe Harbor StatementThis release contains forward-looking statements. These statements are the safe harbor provisions of the U.S disclaimer . These statements can be identified by words or phrases such as will, can be identified expects, anticipates, future, intends, plans, believes, estimates and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Not historical facts not historical facts, including statements about Sinovac’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause the actual results to differ materially in the forward – in the forward – looking statements. Sinovac does not undertake forward-looking statements forward-looking statements, except as required by law.
About Pandemic Influenza Vaccine The Pandemic influenza vaccine being used by Chinese Centers for Disease Control and Prevention and Sinovac Biotech Ltd. Re – assortant H5N1 strain for the development of vaccines jointly developed by The National Institute for Biological Standards and Control . , Sinovac will begin a phase I trial on its proprietary Pandemic Influenza Vaccine . And the process is supported by the Ministry of Science and Technology of the People ‘s Republic of China.
By which John B. John G. Detwiler Professor of Cardiology, professor for medicine and Chairman, Department of Medicine, UMDNJ – Harry Wood Johnson Medical School, UMDNJ – Harry Wood Johnson Medical School and director of medical services of Robert Led Wood Johnson University Hospital, those post-hoc analysis of five-year 10,001 patient TNT study, which was funded by Pfizer, was released in the May 2008 issue of the Journal of Clinical Hypertension. People 10 001 high cholesterol and blood pressure are at greater risk of cardiovascular disease as those with any condition alone.Yet a minority of patients both terms currently recommended handled objectives in a study less than a. Third of this patients were treated and just one treated of ten the target, said Dr. The analysis of today reported reminds us that intensive management of the either cholesterol and blood pressure, considerably reduce may reduce the risk from heart attack and stroke. .